Skip to main content
Quest Diagnostics

Disease Modeling and Pharmacological Rescue of Autosomal Dominant Retinitis Pigmentosa Associated With RHO Copy Number Variation

Disease Modeling and Pharmacological Rescue of Autosomal Dominant Retinitis Pigmentosa Associated With RHO Copy Number Variation

Authors: Kandoi S, Martinez C, Chen KX, Reddy LVK, Mehine M, Mansfield BC, Duncan JL, Lamba DA

Citation: medRxiv [Preprint]. 2023 Nov 6:2023.02.27.23286248. doi: 10.1101/2023.02.27.23286248.

Specialties: Genetics, Neurology

Disclaimer: One or more of the authors of this publication were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics.

Related content

Publication
A novel frameshift variant in CEP78 associated with nonsyndromic retinitis pigmentosa, and a review of CEP78-related phenotypes
Conference Presentation
Optimizing performance of copy number variant caller based on improved baseline selection

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.